Skip to contentD
DNA X, Inc.
D
SONMDNA X, Inc. Q1 2023 · 10-Q
Revenue$25.80M$25.80M+94.6% vs Q1 2022 Net Income$227.00K$227.00KN/M vs Q1 2022 EPS Diluted$0.01$0.01N/M vs Q1 2022 Gross Profit$4,175,000+173.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
Operating Cash Flow-$4,217,000N/M Margins · derivedGross margin16.2%+4.7 pt vs Q1 2022
Operating margin1.3%+54.7 pt vs Q1 2022
Net margin0.9%+55.3 pt vs Q1 2022
ended Mar 31, 2023 · filed May 8, 2023 · 38 d after period end